<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04689139</url>
  </required_header>
  <id_info>
    <org_study_id>039420200002</org_study_id>
    <nct_id>NCT04689139</nct_id>
  </id_info>
  <brief_title>Biomarkers in Thoracic Aorta Surgery</brief_title>
  <official_title>Role of Intraoperative Biomarkers in Prognosis of Perioperative Complications in Reconstructive Thoracic Aorta Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Petrovsky National Research Centre of Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Petrovsky National Research Centre of Surgery</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biomarkers can play a vital role in prognosing the perioperative complications in thoracic&#xD;
      aorta surgery. The goal of a study is to determine the correlation between intraoperative&#xD;
      level of certain biomarkers and total amount of peroperative complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Total amount of various postoperative complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 10 days</time_frame>
    <description>mortality rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiorgan failure</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Number of more than 2 organs failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory failure</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Number of patients who require prolonged and/or repeated artificial lung ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal failure</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Number of patients who require extracorporeal detoxication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Need in medicamental cardiotonic support more than 1 day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulatory insufficiency</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Need in medicamental vasopressor support more than 1 day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection rate</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Number of patients who develop systemic infection and/or operation wound infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of intensive care stay</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Duration of summarized length in ICU, including readmission to ICU</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Aortic Aneurysm</condition>
  <condition>Thoracoabdominal Aneurysm</condition>
  <condition>Aortic Dissection</condition>
  <condition>Complication</condition>
  <arm_group>
    <arm_group_label>Thoracic aorta surgery patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood samples on proadrenomedullin, presepsin, NT-proBNP, Troponin I, procalcitonin are acquired</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood sample tests for determination of biomarkers levels</intervention_name>
    <description>Using of proadrenomedullin, presepsin, NT-proBNP, Troponin I to determine the correlation of perioperative complications.</description>
    <arm_group_label>Thoracic aorta surgery patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective thoracic and thoracoabdominal surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemolysis in blood sample&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Artem Gubko</last_name>
    <phone>+79684241490</phone>
    <email>gubko@artvig.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>Petrovsky Research National Centre of Surgery ( Petrovsky NRCS)</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Artem Gubko</last_name>
      <phone>+79684241490</phone>
      <email>gubko@artvig.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2020</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

